Learn / Conditions / Spine, back and neck
Neuroplastic symptoms · Spine, back and neck

CCSVI: a diagnosis that did not survive the evidence, and what that means for you.

Your symptoms are real. The label is not well supported. That is better news than it sounds, because neuroplastic symptoms can change.

Karuna LabsUpdated 2026-10-146 min read
The short answer

Chronic cerebrospinal venous insufficiency (CCSVI) is a term coined in 2008 to describe narrowed or blocked veins draining the brain and spinal cord, proposed as a cause of multiple sclerosis. Later studies could not confirm it, and in 2012 the US Food and Drug Administration warned that it was unclear whether CCSVI exists as a condition and that the 'liberation' procedures sold to treat it could cause harm. The ATNS Index of Neuroplastic Symptoms states that this diagnosis lacks scientific support, and that symptoms in people given this label are more likely to be neuroplastic symptoms: real symptoms produced by a sensitised nervous system rather than by blocked veins. The good news is that an approach exists that addresses the brain's role, and these symptoms can improve.

This page is about understanding the condition and the role the brain and nervous system can play in it. It is not a diagnosis. Your own clinicians know your case.

What chronic cerebrospinal venous insufficiency is

Chronic cerebrospinal venous insufficiency, or CCSVI, is a term introduced by Italian vascular surgeon Paolo Zamboni in 2008. The idea was that narrowed veins in the neck and chest slowed the flow of blood out of the brain and spinal cord, and that this contributed to multiple sclerosis (MS). The theory spread quickly, and thousands of people travelled abroad for 'liberation therapy', a balloon or stent procedure to widen the veins.

The problem is that independent researchers could not reproduce the original findings. Many people with MS had no venous narrowing, and many healthy people did. In 2012 the US Food and Drug Administration issued a safety communication saying it was not clear that CCSVI exists as a clinical entity and that the procedures carried risks, including serious ones. Later sham-controlled trials did not show a meaningful benefit for MS symptoms. Today, major neurology bodies do not recognise CCSVI as a cause of MS or recommend treating it.

If you have MS, that diagnosis stands on its own evidence and deserves proper neurological care. This page is about the CCSVI label specifically, and about the symptoms attributed to it.

The neuroplastic contribution

Neuroplastic symptoms are real symptoms such as fatigue, brain fog, dizziness, pain, tingling, weakness and heat intolerance that are generated by learned pathways in the brain and nervous system rather than by ongoing damage in the body. The nervous system has become a sensitised alarm. These symptoms are not imaginary and are not 'all in your head' in the dismissive sense. And because the brain can change, they are reversible.

The ATNS Index of Neuroplastic Symptoms is direct about CCSVI: the diagnosis lacks scientific support, and symptoms in people who have been given it are more likely due to neuroplastic symptoms. Here is why that framing fits so many stories:

If you have MS, some symptoms will come from the disease itself and need neurological treatment. But even in MS, fatigue, pain and cognitive fog are often amplified by a sensitised nervous system. Our page on MS explains that overlap.

What the research shows

A 2014 meta-analysis of case-control studies pooled 19 studies comparing venous findings in people with MS and controls. Although the overall pooled result suggested an association, the studies disagreed wildly, and the most conservative analysis found no association at all. The authors noted that the strongest positive results came from investigators who were also involved in promoting the endovascular treatment.

A review titled 'Chronic cerebrospinal venous insufficiency in multiple sclerosis: a failed concept' summarises the arc of the theory, from the original report through the failure of independent replication and the lack of benefit in randomised trials of venoplasty. A 2023 systematic review and meta-analysis covering studies from 2006 to 2022 again found very high heterogeneity between studies and concluded that any link remains unconfirmed.

None of this research directly tests whether symptoms attributed to CCSVI are neuroplastic. What it shows is that the venous explanation does not hold up, which means those symptoms still need an explanation. Central sensitization, described in our explainer, is the best-supported candidate for persistent fatigue, pain and sensory symptoms when no structural cause is found.

Signs the brain may be part of the picture

Try this today

Write a new explanation

Take three minutes with a pen. At the top of a page write the explanation you were given: 'My symptoms are caused by blocked veins.' Underneath, write what the evidence actually says, in your own words: 'Independent studies could not confirm this. My symptoms are real, and they are more likely coming from a sensitised nervous system that can change.' Then list two moments in the past month when a symptom eased, even briefly, and what was happening then. Read both paragraphs aloud. You are not forcing belief; you are giving your brain a safer, more accurate story to work from.

A solution that addresses it

There is an approach that addresses the brain's contribution. It is often called pain and symptom reprocessing. It includes education about neuroplastic symptoms, somatic tracking (observing a sensation with curiosity and safety rather than fear), reducing threat around symptoms, a graded return to activity, emotional awareness and expression, and acceptance and commitment skills. It is delivered by trained clinicians and increasingly through digital programs, and it sits comfortably alongside standard neurological care for anyone who also has MS.

Cindra is a daily AI companion built around these approaches, with daily check-ins, short practices and plain-language lessons for people whose symptoms have a neuroplastic component. If you have been living with symptoms that were blamed on your veins, you can join the waitlist.

What to do next

First, make sure you have a solid neurological assessment. If you have MS, stay with your neurologist and keep any disease-modifying treatment going; do not stop medication on the basis of anything you read here. If you do not have a confirmed diagnosis, ask for one. Seek prompt medical attention for sudden weakness, vision loss, difficulty speaking, loss of bladder or bowel control, or a severe new headache.

Be cautious about clinics offering venoplasty or stenting for CCSVI; the procedure carries real risks and has not been shown to help. Then ask your clinician whether your symptoms fit a neuroplastic pattern. If they might, start learning and practising. The hurt-versus-harm page and the pacing guide are useful first steps.

Questions people ask

Is CCSVI a real condition?

Independent research has not confirmed it. Meta-analyses found inconsistent results, the FDA questioned whether it exists as a clinical entity, and trials of venoplasty did not show benefit. The ATNS Index of Neuroplastic Symptoms lists it as lacking scientific support.

If CCSVI is not real, why do I have symptoms?

Your symptoms are real; the explanation was wrong. The ATNS index says symptoms attributed to CCSVI are more likely neuroplastic symptoms, produced by a sensitised brain and nervous system. If you have MS, some symptoms will also come from that disease and need neurological care.

I felt better after liberation therapy. Doesn't that prove it worked?

Temporary improvement after a procedure is common with placebo and expectation effects, and sham-controlled trials found no real benefit. That response actually points to the brain's role in your symptoms, which is encouraging, because the brain can be retrained without the risks of a vascular procedure.

References

  1. Chronic cerebrospinal venous insufficiency and multiple sclerosis: a comprehensive meta-analysis of case-control studies. 2014. PMID 24587827
  2. Chronic Cerebrospinal Venous Insufficiency in Multiple Sclerosis: A Failed Concept. PMC4480289
  3. Association between chronic cerebrospinal venous insufficiency and multiple sclerosis: a systematic review and meta-analysis. BMJ Open, 2023. PMID 37380203
Source: the definition and neuroplastic-contribution framing on this page summarise, in our own words, the entry “Cerebrospinal Venous Insufficiency” in the Index of Neuroplastic Symptoms (2026) published by the Association for the Treatment of Neuroplastic Symptoms (ATNS, neuroplastic.org). The research summary cites the PubMed records listed above.
Cindra

A daily companion for the hard days and the ordinary ones.

Cindra is an AI companion from Karuna Labs built around acceptance and commitment therapy and the science of neuroplastic symptoms. It checks in with you each day, helps you notice what your symptoms are pulling you away from, and nudges you back toward the things that matter. Cindra is invite-only while we build it with early members.

Join the waitlist

This article is for general education and is not medical advice, and it does not diagnose or treat any condition. Persistent symptoms deserve a proper medical assessment to rule out disease or injury before a neuroplastic explanation is considered. If your symptoms are new, changing, or come with red-flag signs such as fever, unexplained weight loss, numbness or weakness, chest pain, or loss of bladder or bowel control, see a clinician promptly.